Design, Synthesis, and Properties of 2',4'-BNA super(NC): A Bridged Nucleic Acid Analogue

The novel bridged nucleic-acid analogue 2',4'-BNA super(NC) (2'-O,4'- C-aminomethylene bridged nucleic acid), containing a six-membered bridged structure with an N-O linkage, was designed and synthesized efficiently, demonstrating a one-pot intramolecular NC bond-forming key reac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Chemical Society 2008-01, Vol.130 (14), p.4886-4896
Hauptverfasser: Rahman, SMAbdur, Seki, Sayori, Obika, Satoshi, Yoshikawa, Haruhisa, Miyashita, Kazuyuki, Imanishi, Takeshi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The novel bridged nucleic-acid analogue 2',4'-BNA super(NC) (2'-O,4'- C-aminomethylene bridged nucleic acid), containing a six-membered bridged structure with an N-O linkage, was designed and synthesized efficiently, demonstrating a one-pot intramolecular NC bond-forming key reaction to construct a perhydro-1,2-oxazine ring (11 and 12). Three monomers of 2',4'- BNA super(NC) (2',4'-BNA super(NC)[NH], [NMe], and [NBn]) were synthesized and incorporated into oligonucleotides, and their properties were investigated and compared with those of 2',4'-BNA (LNA)-modified oligonucleotides. Compared to 2',4'-BNA (LNA)-modified oligonucleotides, 2',4'-BNA super(NC) congeners were found to possess: (i) equal or higher binding affinity against an RNA complement with excellent single-mismatch discriminating power, (ii) much better RNA selective binding, (iii) stronger and more sequence selective triplex-forming characters, and (iv) immensely higher nuclease resistance, even higher than the S sub(p)-phosphorthioate analogue. 2',4'- BNA super(NC)-modified oligonucleotides with these excellent profiles show great promise for applications in antisense and antigene technologies.
ISSN:1272-7863
1520-5126
DOI:10.1021/ja710342qPII:S0002-7863(71)00342-1